We showed that IMP1 knockdown significantly reduced pancreatic cancer cell proliferation in human PDAC cell lines and three-dimensional spheroids and reduced tumor formation within in vivo Panc-1-derived xenografts. The gene discussed is IGF2BP1; the disease is familial pancreatic carcinoma.